Literature DB >> 28618270

Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.

Nicholas C Wu1, Jia Xie2, Tianqing Zheng2, Corwin M Nycholat3, Geramie Grande2, James C Paulson4, Richard A Lerner5, Ian A Wilson6.   

Abstract

Influenza A virus hemagglutinin (HA) initiates viral entry by engaging host receptor sialylated glycans via its receptor-binding site (RBS). The amino acid sequence of the RBS naturally varies across avian and human influenza virus subtypes and is also evolvable. However, functional sequence diversity in the RBS has not been fully explored. Here, we performed a large-scale mutational analysis of the RBS of A/WSN/33 (H1N1) and A/Hong Kong/1/1968 (H3N2) HAs. Many replication-competent mutants not yet observed in nature were identified, including some that could escape from an RBS-targeted broadly neutralizing antibody. This functional sequence diversity is made possible by pervasive epistasis in the RBS 220-loop and can be buffered by avidity in viral receptor binding. Overall, our study reveals that the HA RBS can accommodate a much greater range of sequence diversity than previously thought, which has significant implications for the complex evolutionary interrelationships between receptor specificity and immune escape.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  X-ray crystallography; deep mutational scanning; epistasis; evolution; hemagglutinin; immune escape; influenza A virus; receptor-binding site; sequence diversity

Mesh:

Substances:

Year:  2017        PMID: 28618270      PMCID: PMC5553561          DOI: 10.1016/j.chom.2017.05.011

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  72 in total

1.  Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.

Authors:  M N Matrosovich; A S Gambaryan; S Teneberg; V E Piskarev; S S Yamnikova; D K Lvov; J S Robertson; K A Karlsson
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

Review 2.  Rates of evolutionary change in viruses: patterns and determinants.

Authors:  Siobain Duffy; Laura A Shackelton; Edward C Holmes
Journal:  Nat Rev Genet       Date:  2008-03-04       Impact factor: 53.242

3.  A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission.

Authors:  Terrence M Tumpey; Taronna R Maines; Neal Van Hoeven; Laurel Glaser; Alicia Solórzano; Claudia Pappas; Nancy J Cox; David E Swayne; Peter Palese; Jacqueline M Katz; Adolfo García-Sastre
Journal:  Science       Date:  2007-02-02       Impact factor: 47.728

4.  The genomic rate of molecular adaptation of the human influenza A virus.

Authors:  Samir Bhatt; Edward C Holmes; Oliver G Pybus
Journal:  Mol Biol Evol       Date:  2011-03-16       Impact factor: 16.240

5.  Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity.

Authors:  Peter S Lee; Reiko Yoshida; Damian C Ekiert; Naoki Sakai; Yasuhiko Suzuki; Ayato Takada; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

6.  A comprehensive biophysical description of pairwise epistasis throughout an entire protein domain.

Authors:  C Anders Olson; Nicholas C Wu; Ren Sun
Journal:  Curr Biol       Date:  2014-10-16       Impact factor: 10.834

7.  Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes.

Authors:  Tokiko Watanabe; Shinji Watanabe; Takeshi Noda; Yutaka Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Cross-neutralization of influenza A viruses mediated by a single antibody loop.

Authors:  Damian C Ekiert; Arun K Kashyap; John Steel; Adam Rubrum; Gira Bhabha; Reza Khayat; Jeong Hyun Lee; Michael A Dillon; Ryann E O'Neil; Aleksandr M Faynboym; Michael Horowitz; Lawrence Horowitz; Andrew B Ward; Peter Palese; Richard Webby; Richard A Lerner; Ramesh R Bhatt; Ian A Wilson
Journal:  Nature       Date:  2012-09-16       Impact factor: 49.962

9.  Avian flu: influenza virus receptors in the human airway.

Authors:  Kyoko Shinya; Masahito Ebina; Shinya Yamada; Masao Ono; Noriyuki Kasai; Yoshihiro Kawaoka
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

10.  Structural Basis for a Switch in Receptor Binding Specificity of Two H5N1 Hemagglutinin Mutants.

Authors:  Xueyong Zhu; Karthik Viswanathan; Rahul Raman; Wenli Yu; Ram Sasisekharan; Ian A Wilson
Journal:  Cell Rep       Date:  2015-11-12       Impact factor: 9.423

View more
  23 in total

1.  Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses.

Authors:  Nicholas C Wu; Andrew J Thompson; Juhye M Lee; Wen Su; Britni M Arlian; Jia Xie; Richard A Lerner; Hui-Ling Yen; Jesse D Bloom; Ian A Wilson
Journal:  Science       Date:  2020-06-19       Impact factor: 47.728

2.  Phenotypic Effects of Substitutions within the Receptor Binding Site of Highly Pathogenic Avian Influenza H5N1 Virus Observed during Human Infection.

Authors:  Dirk Eggink; Monique Spronken; Roosmarijn van der Woude; Jocynthe Buzink; Frederik Broszeit; Ryan McBride; Hana A Pawestri; Vivi Setiawaty; James C Paulson; Geert-Jan Boons; Ron A M Fouchier; Colin A Russell; Menno D de Jong; Robert P de Vries
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.

Authors:  Seth J Zost; Nicholas C Wu; Scott E Hensley; Ian A Wilson
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

4.  Epistatic interactions can moderate the antigenic effect of substitutions in haemagglutinin of influenza H3N2 virus.

Authors:  Björn F Koel; David F Burke; Stefan van der Vliet; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Derek J Smith; Ron A M Fouchier
Journal:  J Gen Virol       Date:  2019-04-24       Impact factor: 3.891

5.  hFUT1-Based Live-Cell Assay To Profile α1-2-Fucoside-Enhanced Influenza Virus A Infection.

Authors:  Senlian Hong; Geramie Grande; Chenhua Yu; Digantkumar G Chapla; Natalie Reigh; Jeong-Yeh Yang; Yi Yang; Ken Izumori; Kelley W Moremen; Jia Xie; Peng Wu
Journal:  ACS Chem Biol       Date:  2020-04-09       Impact factor: 5.100

Review 6.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

7.  Structure-based optimization and synthesis of antiviral drug Arbidol analogues with significantly improved affinity to influenza hemagglutinin.

Authors:  Zoë V F Wright; Nicholas C Wu; Rameshwar U Kadam; Ian A Wilson; Dennis W Wolan
Journal:  Bioorg Med Chem Lett       Date:  2017-06-28       Impact factor: 2.823

Review 8.  A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  J Mol Biol       Date:  2017-06-23       Impact factor: 5.469

9.  Antigenic evolution of human influenza H3N2 neuraminidase is constrained by charge balancing.

Authors:  Yiquan Wang; Ruipeng Lei; Armita Nourmohammad; Nicholas C Wu
Journal:  Elife       Date:  2021-12-08       Impact factor: 8.140

10.  Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.

Authors:  Nicolas Castonguay; Wandong Zhang; Marc-André Langlois
Journal:  Front Microbiol       Date:  2021-06-29       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.